EnLiSense LLC logo — EnLiSense biosensors and platform technologies enables track...

EnLiSense LLC

EnLiSense biosensors and platform technologies enables tracking of WELLNESS to ILLNESS and back to WELLNESS states

Founded 2014 United States Allen, United States 7 employees Grant Health Care, Manufacturing

General Information

Company Name EnLiSense LLC
Founded Year 2014
Location United States Allen, United States +1
Employees 7
Industries Health Care, Manufacturing
Funding Stage Grant
Social

Get notified when EnLiSense LLC moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About EnLiSense LLC

EnLiSense LLC, a sensor device company founded in 2014, is making strides in the health care and manufacturing industries. The company's slogan, "EnLiSense biosensors and platform technologies enables tracking of WELLNESS to ILLNESS and back to WELLNESS states," encapsulates its core mission. EnLiSense specializes in providing innovative biosensing solutions for portable and wearable diagnostic devices. Its current portfolio encompasses non-invasive detection of blood glucose, stress, and inflammatory biomarkers in sweat, as well as the detection and quantification of multiple biomarkers of cardiovascular diseases in small volumes of whole blood. These easy-to-use, reliable, and cost-effective technologies hold promise for diagnostic and prognostic testing of chronic and infectious diseases in home, point-of-care, and ambulatory environments. The last investment in EnLiSense LLC took place on 21 March 2023, with the Crohn's & Colitis Foundation demonstrating confidence in the company's potential. As EnLiSense continues to pioneer advances in biosensing technologies, its emphasis on wellness tracking and diagnostic solutions positions it as a compelling venture capital opportunity in the rapidly evolving health care landscape.

Taxonomy: biosensor technology, wearable diagnostic devices, consumer healthcare, blood glucose monitoring, stress biomarkers, inflammatory biomarkers, cardiovascular disease, chronic disease testing, infectious disease testing, point-of-care diagnostics, ambulatory diagnostics, non-invasive detection, sweat biomarkers, whole blood testing, prognostic testing

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
21 Mar 2023

EnLiSense LLC Alternatives & Competitors

EnLiSense LLC vs

Next generation biomarkers within neurodegenerative diseases for diagnostics and drug development ap...

Grant
9 employees
Biotechnology
EnLiSense LLC vs

BioCifer develops tests that identify pathogens using safe, accurate, and simple kits suitable for p...

2 employees
EnLiSense LLC vs

At JaxBio we develop a blood test for fast, cheap and highly sensitive diagnosis of cancer.

Grant
11 employees
Health Care

FAQ About EnLiSense LLC

EnLiSense biosensors and platform technologies enables tracking of WELLNESS to ILLNESS and back to WELLNESS states
EnLiSense LLC was founded in 2014.
EnLiSense LLC is headquartered in Allen, United States.
EnLiSense LLC operates in the following industries: Health Care, Manufacturing.
EnLiSense LLC has approximately 7 employees.
EnLiSense LLC has completed 1 funding round. The latest funding stage is Grant.
Top alternatives and competitors to EnLiSense LLC include Pre Diagnostics AS, BioCifer Pty Ltd, JaxBio, HeRui BioMed, Ceres Nanosciences, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EnLiSense LLC and Pre Diagnostics AS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors EnLiSense LLC and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy